| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-01-18 |
4 |
S |
$82.66 |
$106,879 |
D/D |
(1,293) |
893,905 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-01-27 |
4 |
S |
$84.70 |
$384,877 |
D/D |
(4,544) |
889,361 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-29 |
4 |
S |
$94.32 |
$252,966 |
D/D |
(2,682) |
1,533,925 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-28 |
4 |
S |
$94.50 |
$241,920 |
D/D |
(2,560) |
1,536,607 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
AS |
$94.96 |
$4,607,334 |
D/D |
(48,515) |
1,644,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
AS |
$94.98 |
$758,237 |
D/D |
(7,982) |
1,679,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-01 |
4 |
AS |
$95.00 |
$3,325,000 |
D/D |
(35,000) |
1,503,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-17 |
4 |
AS |
$95.04 |
$3,326,400 |
D/D |
(35,000) |
1,433,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-12-18 |
4 |
AS |
$95.68 |
$3,348,800 |
D/D |
(35,000) |
1,609,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-02-04 |
4 |
S |
$95.86 |
$1,143,718 |
D/D |
(11,880) |
1,522,045 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-15 |
4 |
AS |
$98.58 |
$3,450,405 |
D/D |
(35,000) |
1,539,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-02 |
4 |
AS |
$99.93 |
$779,754 |
D/D |
(7,803) |
1,601,364 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-09 |
4 |
AS |
$99.96 |
$2,718,612 |
D/D |
(27,197) |
1,574,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-02 |
4 |
AS |
$99.97 |
$829,751 |
D/D |
(8,300) |
1,495,245 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-10 |
4 |
AS |
$100.12 |
$3,504,200 |
D/D |
(35,000) |
1,398,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-04-10 |
4 |
AS |
$100.24 |
$2,676,408 |
D/D |
(26,700) |
1,468,545 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-09 |
4 |
AS |
$100.30 |
$10,843,204 |
D/D |
(108,000) |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-13 |
4 |
AS |
$104.94 |
$652,727 |
D/D |
(6,220) |
1,392,325 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-31 |
4 |
AS |
$104.96 |
$259,251 |
D/D |
(2,470) |
1,673,082 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-16 |
4 |
AS |
$104.97 |
$5,740,924 |
D/D |
(54,548) |
1,036,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-05-14 |
4 |
AS |
$105.38 |
$3,289,759 |
D/D |
(31,113) |
1,361,212 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
AS |
$105.85 |
$6,671,080 |
D/D |
(62,000) |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-07-27 |
4 |
AS |
$106.14 |
$241,150 |
D/D |
(2,272) |
1,879,640 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-15 |
4 |
AS |
$106.36 |
$9,110,847 |
D/D |
(85,452) |
1,091,217 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-07-30 |
4 |
AS |
$109.56 |
$24,384,037 |
D/D |
(212,737) |
1,179,588 |
0 |
- |
|
283 Records found
|
|
Page 8 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
